# Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage

> **NCT05103566** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 25 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DEVICE:** gammaCore

## Key facts

- **NCT ID:** NCT05103566
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-04
- **Primary completion:** 2028-12
- **Final completion:** 2029-04
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103566, "Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage". Retrieved via MORVS 2026-10-09 from https://api.morvs.ai/clinical/NCT05103566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*